QU-CPH MSc graduate wins Best Poster Award
August 02 2018 11:30 PM
local
.

Qatar University College of Pharmacy (QU-CPH) MSc graduate Fatima Khalifa al-Sulaiti has won the Best Poster Award at the 2018 American College of Clinical Pharmacy (ACCP) Virtual Poster Symposium.
Fatima’s abstract on the ‘Outcomes of Peak-trough-based versus Trough-only-based Vancomycin Therapeutic Drug Monitoring Clinical and Pharmacokinetic Approaches: A Pragmatic Randomised Controlled Trial’ was selected from among hundreds in the ACCP Best Poster competition. 
She presented her poster to a panel of expert judges.
The posters were evaluated on the following criteria: originality, rationale and significance; research question, study design and methods; results; discussion/conclusions; and contribution to the research and response to the judges’ questions. 
Fatima has been invited to present the winning poster at the 2018 ACCP Global Conference on Clinical Pharmacy in October.
The winning poster is a product of Fatima’s MSc research project that was supervised by CPH associate professor Dr Ahmed Awaisu and co-supervised by Dr Ahmed Nader (AbbVie Inc principal scientist of Pharmacometrics in the US), Dr Daoud al-Badriyeh (CPH associate professor) and Dr Hazem Elewa (CPH assistant professor).
Dr Mohamed Diab, dean of CPH, said: “Aligning with the College mission to promote research and scholarly activity, we are proud to announce that Ms Fatima Khalifa al-Sulaiti has won the best poster award at the 2018 American College of Clinical Pharmacy Virtual Poster Symposium. Her project will, without a doubt, advance healthcare and serve as a pharmacy resource in Qatar and the Middle East. This is a real reflection on the College of Pharmacy’s research quality and excellence’.
Dr Awaisu added, “We are really proud of Fatima for this significant and tremendous accomplishment. Her project is the first of its kind in Qatar in which the investigators have developed a vancomycin population-specific dosing model for Qatar. This model will allow population-specific calculations of vancomycin pharmacokinetic parameters in individual patients in Qatar’s clinical settings, an important tool in vancomycin dosing and therapy.”


Last updated: August 02 2018 11:31 PM


There are no comments.

LEAVE A COMMENT Your email address will not be published. Required fields are marked*
MORE NEWS

HAPPENING IN DOHAMore